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Metastatic Breast Cancer Presenting as 
Fever, Rash, and Arthritis
Joost P. H. Drenth, M .D .*  Elizabeth H. M. A. de Kleijn, M .D .*
Pieter H. M. de M ulder , M .D .,f and Jos W. M. van der Meer, M D *
Background. Fever can be the presenting symptom of 
metastatic breast carcinoma, but the combination of fe­
ver, polyarthritis, and an erythematous rash as a para­
neoplastic syndrome in breast carcinoma is very rare.
Methods. The clinical course of a 49-year-old female 
with a history of ductal breast carcinoma who presented 
with fever of unknown origin, polyarthritis, and an ery­
thematous rash is described. Moreover, cytokine mea­
surements were performed.
Results. Initially, despite extensive evaluation, a di­
agnosis could not be made. Six weeks after the onset of 
symptoms, a right axillary lymph node became palpable 
and the diagnosis of relapsing breast carcinoma was 
made. Chemotherapy led to defervescence and disappear­
ance of the symptoms. Elevated interleukin-6 and in­
terleukin-1 receptor antagonist concentrations were 
found.
Conclusion. To the authors' knowledge, the severe 
paraneoplastic signs encountered in this patient have not 
been described in breast carcinoma. The presentation is 
even more remarkable in view of the relatively small vis­
ible tumor mass. Cancer 1995;75:1608-11.
Key words; fever of unknown origin, breast carcinoma, 
arthritis, skin lesions, cytokines.
Introduction
Fever is a well recognized presenting symptom of neo­
plastic disease. It has been described in Hodgkin's dis­
ease, leukemia, renal cell carcinoma, and other malig­
nancies.1,2 The diagnosis of neoplastic fever can be no-
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toriously difficult and in the course of the diagnostic 
process, many patients fulfill Peterdorf's criteria for fe­
ver of undetermined origin.3 Fever as an accompanying 
symptom in breast cancer is rare despite the high inci­
dence of the disease.2,4'5 Other symptoms, such as skin 
lesions, disturbances of liver enzymes, and joint in­
volvement are clinical expressions of a heterogeneous 
group of systemic, infectious, and rheumatic illnesses.6 
Although this group of symptoms may be a feature of 
malignant disease, we have not been able to find this 
combination in association with breast cancer.7 We de­
scribe a female who presented with fever of undeter­
mined origin, polyarthritis, and an erythematous rash 
that was associated with a relapse of an initially small, 
metastatic breast carcinoma.
Case Report
4
A 49-year-old postmenopausal woman was referred in June 
1992 to our hospital because of intermittent fever, poly­
arthralgias, and  urticarial rash of 3-week duration. Her m edi­
cal history revealed a bulging disk in 1988 that was treated 
conservatively. In March 1991, she developed a ductal carci­
nom a of her right breast with positive axillary lymph nodes 
(cT2NiMo, pT 2N!Mo). Treatment was delivered by lum pec­
tomy and locoregional irradiation (50 Gy). She was adm itted 
and a 4-week thorough investigation, including com puted to­
m ography scanning of thorax and abdomen, was performed. 
No evidence of infectious disease, autoimmune disorder, or 
m alignancy and especially, recurrence of breast cancer could 
be established. Various antibiotics were prescribed w ithout 
amelioration of the clinical symptoms. Because she fulfilled 
the criteria of Medsger, a tentative diagnosis of adult-onset 
Still's disease was considered and she was given indom etha- 
cine 200 m g daily and naproxen (4 X 250-500 mg) thereaf­
ter.8"11 Despite this treatment she continued to suffer from  
polyarthralgias, chills, and high spiking fever. No diagnosis 
could be m ade and she was discharged without an established 
cause for her fever.3 Two weeks after discharge she was read ­
m itted and on physical examination an ill, dyspnoeic female 
w as seen with a generalized persistent pruritic rash and p a l­
pable erythem atous noduli on the lower legs. A severe poly-
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arthritis was present and symmetrically affected the knee, a n ­
kle, wrist, elbow, and shoulder joints. Careful examination 
further revealed a discrete left supraclavicular (0.5 cm) and  a
right axillary lymph node (1 cm) not present on earlier occa-
i
sions. There was no palpable mass in either breast. She lost 6 
kilos of weight from the time of the onset of her symptoms.
Materials and Methods
Sampling of plasma was performed using special endo­
toxin free tubes (Vacutainer Systems, Becton and Dick­
inson, Rutherford, NJ). The plasma was immediately 
processed to avoid ex vivo cytokine excretion. Tumor 
necrosis factor-a was determined by radioimmuno as­
say as described by Van der Meer et al.12 Interleukin-1/? 
(IL-Iß) was measured by radioimmuno assay (without 
chloroform extraction) according to Lisi et al.13 Interleu­
kin-1 receptor antagonist was determined by radioim­
muno assay according Poutsiaka et al.14 Interleukin-6 
(IL-6) was measured by an enzyme-linked immunosor­
bent assay as described earlier.15
Laboratory Results
Laboratory data were as follows: erythrocyte sedi- 
mentation rate 135 m m /h , hemoglobin 4.2 mmol/% h e­
matocrit 0.22 1/1, white blood cell count 14.9 X 109/1, 
platelets 732 X 109/L serum creatinine 57 fxmol/l, se­
rum albumin 22 g/1, aspartate aminotransferase 7 1 IU /  
1, alanine aminotransferase 29 IU/1, 7 -glutamyl trans­
peptidase 69 IU /l, alkaline phosphatase 474 IU/1. Tu­
mor necrosis factor-ce was 85 pg/m l (normal, 106 ± 25 
pg/m l), IL-1/3 was 75 p g /m l (normal, 134 ± 22 pg/m l), 
IL-6 was 161 pg/m l (normal, <14 pg/m l) and interleu­
kin-1 receptor antagonist was 1300 pg/m l (normal not 
detectable). Rheumatoid factors were negative. A skin 
biopsy from the left leg showed minor perivascular 
lymphocyte infiltration with C3, fibrin, IgM, IgA, and 
IgG vessel deposits. There was no tumor invasion visi­
ble. An indium-111-IgG scintigraphy showed symmet­
ric uptake in the affected joints suggestive of inflam­
mation.16 A 99-Technetium bone scan was negative. A 
computed tomography scan of the thorax now revealed 
a pleural effusion and multiple small intrapulmonary 
densities suggestive of metastasis.
Treatment and Response
The right axillary lymph node was excised and the his­
topathologic examination was compatible with ductal 
breast carcinoma, Disseminated breast cancer was diag­
nosed and the symptoms were accounted as of neoplas­
tic origin.
Chemotherapeutic treatment was initiated with 
oral cyclophosphamide (100 m g /m 2 days 1-14), 5-flu- 
orouracil (600 m g /m 2 days 1 and 8), methotrexate (40 
m g /m 2 days 1 and 8), and prednisone (30 m g/d). Treat­
ment was complicated by a pulmonary embolus of the 
apical part of the left lung. The paraneoplastic signs 
completely disappeared in the course of 3 months. She 
received 9 chemotherapeutic courses in 10 months (3 
cycles) and remission was achieved.
Subsequent Course
4
Twenty-four months later, in September 1994, the pa­
tient presented with a palpable mass of her right breast 
measuring 3.0 by 3.0 cm. A biopsy specimen was con­
sistent with a (second) primary ductal breast carcinoma. 
Radiodiagnostic imaging revealed now  diffuse sclerotic 
metastasis of the spine, pelvis, humerus, and femur, 
which matched with hot spots on the 99-Technetium  
bone scan. There were no symptoms related to the tu­
mor and the patient specifically denied bone pain, ar­
thralgias, fever, and skin lesions. After treatment initia­
tion with tamoxifen (40 m g/day), within 3 days the pa­
tient developed generalized bone pain, arthralgia and 
later on fever and a recurrence of anemia. In view of 
severity of symptoms and no alleviation during 6 weeks 
of treatment, medication was discontinued. Evaluation 
revealed no tumor progression. The symptoms dimin­
ished slightly but did not disappear. The IL-lra concen­
tration remained elevated, with 1050 pg/m l but the IL- 
6 concentration was now  only 22.5 pg/m l. Concentra­
tions of tumor necrosis factor-a: (65 pg/m l) and IL-1/3 
(85 pg/m l) were normal.
Discussion
Signs and/or symptoms that are produced at a. distance 
from the tumor and/or métastasés are referred to as 
paraneoplastic syndrome. These symptoms occur only 
in a minority (7-15%) of cancer patients and respond to 
treatment of the underlying malignancy .17 Our patient 
with severe paraneoplastic signs is presented for three 
reasons: (1) to our knowledge, the impressive paraneo­
plastic symptoms never have been described in (metas­
tasized) breast carcinoma; (2) the extent of the paraneo­
plastic symptoms is remarkable considering the rela­
tively small detectable tumor mass; and (3) in cases of 
fever of undetermined origin, breast carcinoma as a 
cause should be considered. The paraneoplastic symp­
toms in our patient included fever, polyarthritis, an er­
ythematous rash, liver function disturbances, and 
weight loss. A computer-aided search (Medline, 
National Library of Medicine, Bethesda, MD) using the
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keywords "fever," "breast carcinoma/' and "(polyar­
thritis" for 1966-1993 did not yield any particular re­
ports, emphasizing the unique presentation of our pa­
tient. Chawla et al. found only 17 patients with recur­
rent unexplained fever that could be interpreted as 
tumor-associated fever among 2400 patients with 
breast cancer. In only 7 patients (41%) fever was the 
first manifestation of recurrence of the disease, in the 
other 10 patients fever developed with progression of 
the disease. Apart from fever, there is no reference to 
other paraneoplastic signs in these patients with breast 
cancer.5 Whereas fever is a well recognized manifesta­
tion of occult malignancy, it is rarely accompanied by 
polyarthritis. The articular symptoms in our patient 
progressed from (poly)arthralgias to severe polyarthritis 
in only a few weeks. The response to the chemotherapy 
suggests the causal relation with breast carcinoma in 
our patient. Paraneoplastic acute polyarthritis is infre­
quent but has been recognized in squamous lung cancer 
and ovarian adenocarcinoma.7,18,19 In a report of 18 pa­
tients with paraneoplastic polyarthritis, only 3 were as­
sociated with breast carcinoma and other paraneoplas­
tic symptoms were lacking.20 The symptoms in our pa­
tient matched the adapted criteria for adult-onset Still's 
disease.8 It is claimed that these criteria have a sensitiv­
ity of 96.2% and a specificity of 92.1%, but the diagno­
sis remains to be made by exclusion as illustrated in our 
case. Moreover, the response to nonsteroidal antiin­
flammatory drugs and the evanescent maculopapular 
rash typical for adult onset Still's disease were lacking 
in our patient. The use of naproxen in order to differ­
entiate malignant fever from fever of other causes did 
not offer any clues in our patient with neoplastic fe­
ver.10,11 The usefulness of the test may be limited as it 
has only been studied in selected populations. The 
pathogenesis of paraneoplastic symptoms remains to be 
elucidated but in a mice model with a paraneoplastic 
syndrome of cachexia, hypercalcemia, and leukocyto­
sis, tumor necrosis factor played a causal role.21 In our 
patient, we did not find an elevated tumor necrosis fac­
tor concentration in circulating plasma, but this does 
not exclude a role of this cytokine as a local mediator of 
paraneoplastic symptoms. In contrast to IL-lß, its in­
hibitor (IL-lra) was elevated and this suggest an activa­
tion of the cytokine network. In addition, IL-6 concen­
trations were elevated in our patient. This cytokine is 
a major modulator of the acute phase reaction that is 
characterized by fever, leukocytosis, increased vascular 
permeability, and elevation of acute phase proteins, all 
present in our patient.22 It remains possible that other, 
perhaps locally produced, inflammatory compounds 
are responsible for the paraneoplastic symptoms. In this 
respect it has been shown that breast tumors produce
higher amounts of prostaglandin-like material in vivo 
compared with normal breast tissue.23 The second pri­
mary breast carcinoma was, at time of the diagnosis, 
not associated with reappearance of the paraneoplastic 
symptoms. However, after initiation of tamoxifen treat­
ment, fever and arthralgia reappeared. During this pe­
riod, IL-lra concentration was elevated but IL-6 con­
centration was only slightly increased, Our patient ex­
emplifies the difficulties in reaching a diagnosis in case 
of fever of unexplained origin, even when diagnostic 
clues are present.
It should be emphasized that in patients with a his­
tory of cancer presenting with fever of unknown origin 
the diagnostic process should be first be focused on the 
possible recurrence of the malignancy.
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